-
February 03, 2012
Reaction to AstraZeneca's announcement that some 7,300 jobs would be axed by the end of 2014 has continued, and it seems that the firm's UK research staff will be reduced by 250-350 posts
-
February 03, 2012
Merck KGaA has linked up with the USA's Threshold Pharmaceutical to co-develop and commercialise the latter's late-stage hypoxia-targeted drug for certain cancers
-
February 03, 2012
Merck & Co's fourth-quarter sales have been boosted by good performances from diabetes drugs Januvia and Janumet and the cervical cancer vaccine Gardasil, but the US giant is expecting a tough 2012
-
February 03, 2012
Novo Nordisk has posted a healthy set of figures for the fourth quarter, helped by strong sales of diabetes drug Victoza
-
February 03, 2012
The US Affordable Care Act (ACA) saved nearly 3.6 million people enrolled in the US Medicare programme some $2.1 billion on their prescription drugs last year, says the government.
-
February 02, 2012
Speculation that AstraZeneca was to drastically cut its workforce was realised today when the Anglo-Swedish drugmaker announced some 7,300 jobs would be axed.
-
February 02, 2012
US health officials have introduced a proposed new rule which they say will save the country $17.7 billion over five years on prescription drugs purchased through the state/federal Medicaid programme.
-
February 02, 2012
The European Commission has given Italy two months to comply with European Union rules concerning the provision of marketing authorisations for generic drugs.
-
February 02, 2012
Fitch Ratings says its outlook on India's pharmaceutical sector for 2012 remains stable, with earnings prospects remaining positive because of the growing global demand for generics and opportunities provided by patent expiries in developed markets.
-
February 01, 2012
Roche’s 2011 earnings may have experienced a 4% drop but the company is remaining optimistic about growth in the new year as new products flood onto the market.